Pharmafile Logo

The role of medical affairs in positive and appropriate engagement with patient advocacy groups

January 30, 2020 |  

Written by Gavin Jones, Dr Alexandra Safronova & Professor Peter Rutherford, OPEN Health

Following a series of workshops at a recent Medical Affairs Professionals Society (MAPS) Congress in Amsterdam, workshop leaders Gavin Jones, Dr Alexandra Safronova and Professor Peter Rutherford share their lessons learnt on how medical affairs departments within pharmaceutical companies can help create better partnerships with patient advocacy groups

Pink divider

Patient advocacy groups continue to mobilise and play an increasingly important role in delivering advice and support helping to get treatments to those most in need by Influencing many elements of drug development and patient access processes. This is very much the case in rare disease where groups give critical support to patients and those close to them through influential programmes delivered  with passion and dogged persistence.

Biopharma recognises the importance of positive engagement and partnership with patient groups. Gaining a far greater understanding of the patient journey helps to translate innovations into actual benefits for patients and caregivers in improved clinical outcomes and patient experience.

A question remains around how, and which part of a biopharma organisation should be involved in building patient group relationships. Many organisations invest in patient advocacy leads to support engagement, but they are often brought in to support dialogue as new treatment is becoming available.  As   patient  groups  are  rightly  getting involved in activities much earlier in the drug development process who should lead engagement at this stage and support over the longer term?

This was a question that was posed at workshops during the recent Medical Affairs Professionals (MAPS) meeting in Europe. MAPS is an organisation that supports the sharing of best practice amongst leaders in this key function of pharmaceutical companies. So, who are medical affairs and what is their role?

Read the full article here: https://bit.ly/37IYg5

Pink divider

Get in touch

For more information on rare disease contact:

Gavin Jones, Director of Rare Disease, OPEN Health

Gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

Announcing OPEN Health New Communications CEO, Margot Hannah

OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications

OPEN Health Acquires ARK

OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities

Rare thoughts & outcomes – navigating pathways to better outcomes in rare

Mobilizing pathway change – what the past 25 years have shown meWelcome to OPEN Health’s second Rare Thoughts & Outcomes theme for 2021 – Navigating pathways to better outcomes. This...

How to pick the perfect training program for your healthcare professionals

You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...

Maximize your training investments with learning and development specialists

Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can...

A day in the life of a PR Account Director

We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health

OPEN Health acquires UK medical communications agency Spirit

OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.

OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021

We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).